Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deuterated Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461624B reveals a breakthrough method for selective C4/C5 mono-deuteration of 1,2,3-triazoles, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel Rh-catalyzed method for selective benzylic deuteration offers high purity and scalability for API manufacturing, reducing costs and improving supply chain reliability for deuterated drugs.
Discover the advanced preparation method for (2S)-3-deuterium-L-valine esters disclosed in CN113461573B, offering high yield and benzene-free processing for deuterated drug manufacturing.
Patent CN113354498B enables metal-free deuteration. Enhances supply chain reliability and reduces manufacturing costs for high-purity pharmaceutical intermediates.
Patent CN114349585A details a copper-catalyzed asymmetric synthesis of chiral alpha-deuterated pyrrolidines using D2O, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel SmI2-catalyzed reductive deuteration of nitriles offers high yield and regioselectivity. A cost-effective supply chain solution for deuterated drug manufacturing.
Patent CN112430187A reveals a novel SmI2-catalyzed reductive deuteration method for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN114438532A reveals a green electrochemical method for deoxydeuteration. Enables cost reduction in API manufacturing with high purity and scalability.
Patent CN113651663A reveals a green one-pot palladium-catalyzed method for ortho-deuteration, offering reliable supply chain solutions and cost reduction in pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed route for high-purity deuterated intermediates. Cost-effective, scalable manufacturing for pharmaceutical applications using aryl sulfur salts.
Patent CN117187839A reveals electrocatalytic synthesis of gamma-deuterated pyridines. Offers green, cost-effective solutions for deuterated drug intermediate manufacturing and supply chain stability.
Patent CN111039767B reveals a metal-free route for deuterated aldehydes using triazole carbene, offering high deuteration rates and cost efficiency for pharmaceutical supply chains.
Patent CN114656347B reveals efficient palladium-catalyzed synthesis. Offers high deuteration rates and scalable routes for pharmaceutical intermediates supply chain optimization.
Patent CN113354498A reveals a metal-free method for reducing aromatic C-N/O/halogen bonds to C-H/D bonds using light induction, offering significant cost reduction in API manufacturing and high-purity deuterated compounds.
Solve explosive risks and metal residues in deuterated synthesis. Achieve 99% deuteration with no catalysts. Scale to 100 MT/annual for drug development.